Tardive dyskinesia in Asia- current clinical practice and the role of neurologists in the care pathway.
Ontology highlight
ABSTRACT: Tardive dyskinesia (TD) is a movement disorder that can arise as a side effect of treatment with dopamine receptor-blocking agents (DRBAs), including antipsychotic drugs (APDs) used to manage psychotic illnesses. Second-generation APDs (SGAs) are often preferred to first-generation drugs due to their lower propensity to cause TD, however many SGAs-treated patients still develop the condition. Although TD is a global health concern, evidence regarding the occurrence of TD and how it is managed in Asian countries is currently limited. This article reports the results of a systematic review of the published literature on TD focusing on its prevalence, types of patients, knowledge of the condition, causative factors, and usual treatment pathways in clinical practice in Asian countries. Epidemi
SUBMITTER: Bhidayasiri R
PROVIDER: S-EPMC10901179 | biostudies-literature | 2024
REPOSITORIES: biostudies-literature
ACCESS DATA